Clinical trials
Aneuploidy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Unknown status | 14 |
| Recruiting | 7 |
| Terminated | 7 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Igenomix | 5 |
| Sequenom, Inc. | 4 |
| ART Fertility Clinics LLC | 3 |
| Women and Infants Hospital of Rhode Island | 3 |
| Assisting Nature | 2 |
| Cindy Cisneros | 2 |
| Federico II University | 2 |
| Instituto Valenciano de Infertilidad, IVI VALENCIA | 2 |
| Natera, Inc. | 2 |
| Universitair Ziekenhuis Brussel | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aneuploidy | 69 |
| Infertility | 26 |
| Down Syndrome | 15 |
| Chromosome Aberrations | 8 |
| Trisomy 18 Syndrome | 8 |
| Trisomy 13 Syndrome | 6 |
| Abortion, Spontaneous | 4 |
| Trisomy | 4 |
| Turner Syndrome | 4 |
| DiGeorge Syndrome | 3 |
Trials
Showing 51 to 69 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.